|Articles|March 1, 2016
- BioPharm International-03-01-2016
- Volume 29
- Issue 3
BioPharm International, March 2016 Issue (PDF)
Click the title above to open the BioPharm International March 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 10 years ago
Achieving Cost-Effective Bioprocessesalmost 10 years ago
Generic-Drug Production and Oversight Challenge FDA and Manufacturersalmost 10 years ago
Biopharma Takes On Raw Material Variabilityalmost 10 years ago
Keynote Series Addresses Crucial Industry Issuesalmost 10 years ago
How Important is Data Integrity to Regulatory Bodies?almost 10 years ago
Biopharma Outsourcing Market Expandsalmost 10 years ago
Cold Chain: Going the Extra Milealmost 10 years ago
Creating Robust CAPA SystemsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Developing Next-Gen Cell Lines Using Targeted Integration
2
FAQ: What You Need to Know about the Current Antibody Pipeline
3
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
4
EU Clears Subcutaneous Biologic for Lupus, Advancing Patient-Controlled Delivery
5
